Supreme Drugs Private Limited, a active private limited company, was established on 27 August 2021 in Banaskatha, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24290GJ2021PTC125153. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Jayantilal Maganlal Patel (Director), Ashokkumar Hiralal Patel (Director), Dineshkumar Ramabhai Panchasara (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shree Tirupati Ind, Ta-Palanpur, Village Dist- Banaskatha,, Banaskatha, Gujarat, 385001.
U24290GJ2021PTC125153
125153
27 August 2021
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Supreme Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayantilal Maganlal Patel | Director | 01 Nov 2023 | Current |
| Ashokkumar Hiralal Patel | Director | 27 Aug 2021 | Current |
| Dineshkumar Ramabhai Panchasara | Director | 27 Aug 2021 | Current |
| Keshav Deo | Director | 17 Feb 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Supreme Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2528.73% increase. The company also saw a substantial improvement in profitability, with a 35.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Supreme Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Supreme Drugs has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Supreme Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreme Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Supreme Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Supreme Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Jayantilal Maganlal Patel was appointed as a Director was appointed as a Director on 01 Nov 2023 & has been associated with this company since 2 years 28 days . was completed.
Keshav Deo was appointed as a Director was appointed as a Director on 17 Feb 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.
The activity Ashokkumar Hiralal Patel was appointed as a Director was appointed as a Director on 27 Aug 2021 & has been associated with this company since 4 years 3 months . was completed.
Dineshkumar Ramabhai Panchasara was appointed as a Director was appointed as a Director on 27 Aug 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
The CIN of Supreme Drugs Private Limited is U24290GJ2021PTC125153.
Supreme Drugs Private Limited is headquartered at Shree Tirupati Ind, Ta-Palanpur, Village Dist- Banaskatha,, Banaskatha, Gujarat, 385001.
Supreme Drugs Private Limited was incorporated on 27 August 2021.
The current directors of Supreme Drugs Private Limited are
The primary industry of Supreme Drugs Private Limited is Manufacturing.
Supreme Drugs Private Limited is unlisted.
The authorized capital of Supreme Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Supreme Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX